These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 8365293)
1. No increase in plasma histamine during PAF-induced airway obstruction in allergic asthmatics. Louis R; Bury T; Corhay JL; Radermecker M Chest; 1993 Sep; 104(3):806-10. PubMed ID: 8365293 [TBL] [Abstract][Full Text] [Related]
2. Acute bronchial and hematologic effects following inhalation of a single dose of PAF. Comparison between asthmatics and normal subjects. Louis R; Bury T; Corhay JL; Radermecker MF Chest; 1994 Oct; 106(4):1094-9. PubMed ID: 7924479 [TBL] [Abstract][Full Text] [Related]
3. Inhaled platelet-activating factor increases airway sensitivity but not maximal airway narrowing to methacholine in normal subjects. Bellofiore S; Ciancio N; Pennisi A; Coco G; Passanisi G; Ricciardolo FL; Novo S; Di Maria GU Monaldi Arch Chest Dis; 1994 Sep; 49(4):288-92. PubMed ID: 8000412 [TBL] [Abstract][Full Text] [Related]
4. Acute bronchial obstruction following inhalation of PAF in asthmatic and normal subjects: comparison with methacholine. Louis RE; Radermecker MF Eur Respir J; 1996 Jul; 9(7):1414-20. PubMed ID: 8836652 [TBL] [Abstract][Full Text] [Related]
5. Effect of PAF-acether inhalation on nonspecific bronchial reactivity and adrenergic response in normal and asthmatic subjects. Hopp RJ; Bewtra AK; Nabe M; Agrawal DK; Townley RG Chest; 1990 Oct; 98(4):936-41. PubMed ID: 2209152 [TBL] [Abstract][Full Text] [Related]
6. Changes in bronchial responsiveness, circulating leucocytes and ex vivo cytokine production by blood monocytes after PAF inhalation in allergic asthmatics. Louis R; Degroote D; Bury T; Corhay JL; Kayembe JM; Franchimont P; Radermecker MF Eur Respir J; 1995 Apr; 8(4):611-8. PubMed ID: 7664863 [TBL] [Abstract][Full Text] [Related]
7. Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma. Howarth PH; Durham SR; Lee TH; Kay AB; Church MK; Holgate ST Am Rev Respir Dis; 1985 Nov; 132(5):986-92. PubMed ID: 2932989 [TBL] [Abstract][Full Text] [Related]
8. Effects of platelet activating factor on airway calibre, airway responsiveness, and circulating cells in asthmatic subjects. Chung KF; Barnes PJ Thorax; 1989 Feb; 44(2):108-15. PubMed ID: 2648646 [TBL] [Abstract][Full Text] [Related]
9. The relationship between mast cell-mediator release and bronchial reactivity in allergic asthma. Howarth PH; Durham SR; Kay AB; Holgate ST J Allergy Clin Immunol; 1987 Nov; 80(5):703-11. PubMed ID: 2445803 [TBL] [Abstract][Full Text] [Related]
10. Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma. Gómez FP; Roca J; Barberà JA; Chung KF; Peinado VI; Rodriguez-Roisin R Eur Respir J; 1998 Apr; 11(4):835-9. PubMed ID: 9623685 [TBL] [Abstract][Full Text] [Related]
11. The bronchoconstrictor properties of platelet-activating factor in humans. Rubin AH; Smith LJ; Patterson R Am Rev Respir Dis; 1987 Nov; 136(5):1145-51. PubMed ID: 3314611 [TBL] [Abstract][Full Text] [Related]
12. Bronchoconstriction and eosinophil recruitment in guinea pig lungs after platelet activating factor administration. Lin CC; Lin CY J Asthma; 1997; 34(2):153-60. PubMed ID: 9088302 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans. O'Connor BJ; Uden S; Carty TJ; Eskra JD; Barnes PJ; Chung KF Am J Respir Crit Care Med; 1994 Jul; 150(1):35-40. PubMed ID: 8025768 [TBL] [Abstract][Full Text] [Related]
14. Persistence of airway obstruction and hyperresponsiveness in subjects with asthma remission. Boulet LP; Turcotte H; Brochu A Chest; 1994 Apr; 105(4):1024-31. PubMed ID: 8162720 [TBL] [Abstract][Full Text] [Related]
15. Effects of inhaled PAF in humans on circulating and bronchoalveolar lavage fluid neutrophils. Relationship to bronchoconstriction and changes in airway responsiveness. Wardlaw AJ; Chung KF; Moqbel R; MacDonald AJ; Hartnell A; McCusker M; Collins JV; Barnes PJ; Kay AB Am Rev Respir Dis; 1990 Feb; 141(2):386-92. PubMed ID: 2405759 [TBL] [Abstract][Full Text] [Related]
16. Platelet activating factor does not cause a reproducible increase in bronchial responsiveness in normal man. Spencer DA; Green SE; Evans JM; Piper PJ; Costello JF Clin Exp Allergy; 1990 Sep; 20(5):525-32. PubMed ID: 2253083 [TBL] [Abstract][Full Text] [Related]
17. Effect of inhaled platelet-activating factor on circulating neutrophils and platelets in vivo and ex vivo in man. Kioumis I; Lammers JW; Dent G; Chung KF; Barnes PJ Prostaglandins; 1988 Sep; 36(3):343-54. PubMed ID: 3237997 [TBL] [Abstract][Full Text] [Related]
18. [Effects of inhaled aerosol of platelet activating factor on pulmonary function and airway responsiveness in normal subjects]. Li Q Zhonghua Jie He He Hu Xi Za Zhi; 1992 Aug; 15(4):222-4, 255. PubMed ID: 1307517 [TBL] [Abstract][Full Text] [Related]
19. Failure of salmeterol to inhibit circulating white cell responses and bronchoconstriction induced by platelet activating factor. Spring J; Johnston SR; Seale J; Ind PW Thorax; 1992 Nov; 47(11):948-51. PubMed ID: 1361250 [TBL] [Abstract][Full Text] [Related]
20. Adenosine-induced bronchoconstriction in asthma. Antagonism by inhaled theophylline. Cushley MJ; Tattersfield AE; Holgate ST Am Rev Respir Dis; 1984 Mar; 129(3):380-4. PubMed ID: 6703496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]